Cargando...
Advances in the Treatment of Polycythemia Vera: Trends in Disease Management
Treatment modalities for polycythemia vera (PV) have evolved over time. Phlebotomy and low-dose aspirin suffice in low-risk patients, but cytoreductive therapies are indicated in all high-risk patients (age ≥ 65 years or those with a history of PV-related thrombotic event) and may be considered for...
Guardado en:
| Publicado en: | Cureus |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Cureus
2021
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8084584/ https://ncbi.nlm.nih.gov/pubmed/33936902 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.14193 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|